The DOI matches its Crossref record; 200 of the 200 references it cites were found in a registry or an index.
Epithelial–mesenchymal transition: a new target in anticancer drug discovery
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedEpithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302
Regulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302
Feig, C., Jones, J. O., Kraman, M., Wells, R. J. B., Deonarine, A., Chan, D. S., Connell, C. M., Roberts, E. W., Zhao, Q., Caballero, O. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320318110 · Cited by 2,100
Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070
Zheng, X., Carstens, J. L., Kim, J., Scheible, M., Kaye, J., Sugimoto, H., Wu, C.-C., LeBleu, V. S., & Kalluri, R. (2015) · Nature · doi:10.1038/nature16064 · Cited by 2,032
WNT signalling pathways as therapeutic targets in cancer
Anastas, J. N., & Moon, R. T. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3419 · Cited by 1,911
Fischer, K. R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S. T. C., Choi, H., El Rayes, T., Ryu, S., Troeger, J., et al. (2015) · Nature · doi:10.1038/nature15748 · Cited by 1,791
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Diaz Jr, L. A., Williams, R. T., Wu, J., Kinde, I., Hecht, J. R., Berlin, J., Allen, B., Bozic, I., Reiter, J. G., Nowak, M. A., et al. (2012) · Nature · doi:10.1038/nature11219 · Cited by 1,713
Loss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional Pathways
Onder, T. T., Gupta, P. B., Mani, S. A., Yang, J., Lander, E. S., & Weinberg, R. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2938 · Cited by 1,522
Hypoxia and the extracellular matrix: drivers of tumour metastasis
Gilkes, D. M., Semenza, G. L., & Wirtz, D. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3726 · Cited by 1,520
MicroRNAs and other non-coding RNAs as targets for anticancer drug development
Ling, H., Fabbri, M., & Calin, G. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4140 · Cited by 1,465
Creighton, C. J., Li, X., Landis, M., Dixon, J. M., Neumeister, V. M., Sjolund, A., Rimm, D. L., Wong, H., Rodriguez, A., Herschkowitz, J. I., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905718106 · Cited by 1,412
Ries, C. H., Cannarile, M. A., Hoves, S., Benz, J., Wartha, K., Runza, V., Rey-Giraud, F., Pradel, L. P., Feuerhake, F., Klaman, I., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.016 · Cited by 1,384
FAK in cancer: mechanistic findings and clinical applications
Sulzmaier, F. J., Jean, C., & Schlaepfer, D. D. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3792 · Cited by 1,381
The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells
Cordenonsi, M., Zanconato, F., Azzolin, L., Forcato, M., Rosato, A., Frasson, C., Inui, M., Montagner, M., Parenti, A. R., Poletti, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.048 · Cited by 1,381
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Ma, L., Young, J., Prabhala, H., Pan, E., Mestdagh, P., Muth, D., Teruya-Feldstein, J., Reinhardt, F., Onder, T. T., Valastyan, S., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2024 · Cited by 1,336
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Madiraju, A. K., Erion, D. M., Rahimi, Y., Zhang, X.-M., Braddock, D. T., Albright, R. A., Prigaro, B. J., Wood, J. L., Bhanot, S., MacDonald, M. J., et al. (2014) · Nature · doi:10.1038/nature13270 · Cited by 1,284
The epigenetics of epithelial-mesenchymal plasticity in cancer
Tam, W. L., & Weinberg, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3336 · Cited by 1,163
Hirsch, H. A., Iliopoulos, D., Tsichlis, P. N., & Struhl, K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2994 · Cited by 1,115
Klug, F., Prakash, H., Huber, P. E., Seibel, T., Bender, N., Halama, N., Pfirschke, C., Voss, R. H., Timke, C., Umansky, L., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.09.014 · Cited by 1,099
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
Acharyya, S., Oskarsson, T., Vanharanta, S., Malladi, S., Kim, J., Morris, P. G., Manova-Todorova, K., Leversha, M., Hogg, N., Seshan, V. E., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.042 · Cited by 1,085
Tsai, J. H., Donaher, J. L., Murphy, D. A., Chau, S., & Yang, J. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.022 · Cited by 1,071
Bracken, C. P., Gregory, P. A., Kolesnikoff, N., Bert, A. G., Wang, J., Shannon, M. F., & Goodall, G. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1942 · Cited by 1,060
Byers, L. A., Diao, L., Wang, J., Saintigny, P., Girard, L., Peyton, M., Shen, L., Fan, Y., Giri, U., Tumula, P. K., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1558 · Cited by 1,059
Taube, J. H., Herschkowitz, J. I., Komurov, K., Zhou, A. Y., Gupta, S., Yang, J., Hartwell, K., Onder, T. T., Gupta, P. B., Evans, K. W., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004900107 · Cited by 1,041
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
Kortylewski, M., Kujawski, M., Wang, T., Wei, S., Zhang, S., Pilon-Thomas, S., Niu, G., Kay, H., Mulé, J., Kerr, W. G., et al. (2005) · Nature Medicine · doi:10.1038/nm1325 · Cited by 1,031
Vinci, M., Gowan, S., Boxall, F., Patterson, L., Zimmermann, M., Court, W., Lomas, C., Mendiola, M., Hardisson, D., & Eccles, S. A. (2012) · BMC Biology · doi:10.1186/1741-7007-10-29 · Cited by 1,024
New Users of Metformin Are at Low Risk of Incident Cancer
Libby, G., Donnelly, L. A., Donnan, P. T., Alessi, D. R., Morris, A. D., & Evans, J. M. M. (2009) · Diabetes Care · doi:10.2337/dc08-2175 · Cited by 996
EMT: When epithelial cells decide to become mesenchymal-like cells
Kalluri, R. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39675 · Cited by 952
Enhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein
Yu, C.-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., & Jove, R. (1995) · Science · doi:10.1126/science.7541555 · Cited by 931
The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
Johnson, R., & Halder, G. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4161 · Cited by 881
Snail blocks the cell cycle and confers resistance to cell death
Vega, S., Morales, A. V., Ocaña, O. H., Valdés, F., Fabregat, I., & Nieto, M. A. (2004) · Genes & Development · doi:10.1101/gad.294104 · Cited by 867
Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
Germano, G., Frapolli, R., Belgiovine, C., Anselmo, A., Pesce, S., Liguori, M., Erba, E., Uboldi, S., Zucchetti, M., Pasqualini, F., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.008 · Cited by 864
Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast
Scheel, C., Eaton, E. N., Li, S. H.-J., Chaffer, C. L., Reinhardt, F., Kah, K.-J., Bell, G., Guo, W., Rubin, J., Richardson, A. L., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.029 · Cited by 858
Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond
Holderfield, M., Deuker, M. M., McCormick, F., & McMahon, M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3760 · Cited by 833
Notch signaling mediates hypoxia-induced tumor cell migration and invasion
Sahlgren, C., Gustafsson, M. V., Jin, S., Poellinger, L., & Lendahl, U. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802047105 · Cited by 823
Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer
Dong, C., Yuan, T., Wu, Y., Wang, Y., Fan, T. W. M., Miriyala, S., Lin, Y., Yao, J., Shi, J., Kang, T., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.022 · Cited by 804
Tan, T. Z., Miow, Q. H., Miki, Y., Noda, T., Mori, S., Huang, R. Y., & Thiery, J. P. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404208 · Cited by 792
Su, S., Liu, Q., Chen, J., Chen, J., Chen, F., He, C., Huang, D., Wu, W., Lin, L., Huang, W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.021 · Cited by 772
Lou, Y., McDonald, P. C., Oloumi, A., Chia, S., Ostlund, C., Ahmadi, A., Kyle, A., auf dem Keller, U., Leung, S., Huntsman, D., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4261 · Cited by 755
Hypoxia and hypoxia-inducible factors: master regulators of metastasis
Lu, X., & Kang, Y. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1360 · Cited by 723
Goetz, J. G., Minguet, S., Navarro-Lérida, I., Lazcano, J. J., Samaniego, R., Calvo, E., Tello, M., Osteso-Ibáñez, T., Pellinen, T., Echarri, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.05.040 · Cited by 720
Todaro, M., Gaggianesi, M., Catalano, V., Benfante, A., Iovino, F., Biffoni, M., Apuzzo, T., Sperduti, I., Volpe, S., Cocorullo, G., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.01.009 · Cited by 717
Self-citationAnsieau, S., Bastid, J., Doreau, A., Morel, A.-P., Bouchet, B. P., Thomas, C., Fauvet, F., Puisieux, I., Doglioni, C., Piccinin, S., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.005 · Cited by 715
Src kinases as therapeutic targets for cancer
Kim, L. C., Song, L., & Haura, E. B. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.129 · Cited by 700
Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
Lee, H., Herrmann, A., Deng, J.-H., Kujawski, M., Niu, G., Li, Z., Forman, S., Jove, R., Pardoll, D. M., & Yu, H. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.02.015 · Cited by 683
Secreted and transmembrane wnt inhibitors and activators
Cruciat, C.-M., & Niehrs, C. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a015081 · Cited by 646
Casazza, A., Laoui, D., Wenes, M., Rizzolio, S., Bassani, N., Mambretti, M., Deschoemaeker, S., Van Ginderachter, J. A., Tamagnone, L., & Mazzone, M. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.11.007 · Cited by 629
Wang, Z., Li, Y., Kong, D., Banerjee, S., Ahmad, A., Azmi, A. S., Ali, S., Abbruzzese, J. L., Gallick, G. E., & Sarkar, F. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4312 · Cited by 619
Gurney, A., Axelrod, F., Bond, C. J., Cain, J., Chartier, C., Donigan, L., Fischer, M., Chaudhari, A., Ji, M., Kapoun, A. M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120068109 · Cited by 614
Giannoni, E., Bianchini, F., Masieri, L., Serni, S., Torre, E., Calorini, L., & Chiarugi, P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0785 · Cited by 596
Chua, H. L., Bhat-Nakshatri, P., Clare, S. E., Morimiya, A., Badve, S., & Nakshatri, H. (2007) · Oncogene · doi:10.1038/sj.onc.1209808 · Cited by 596
Gjerdrum, C., Tiron, C., Høiby, T., Stefansson, I., Haugen, H., Sandal, T., Collett, K., Li, S., McCormack, E., Gjertsen, B. T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909333107 · Cited by 594
The rationale for targeting the LOX family in cancer
Barker, H. E., Cox, T. R., & Erler, J. T. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3319 · Cited by 590
TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
Bhola, N. E., Balko, J. M., Dugger, T. C., Kuba, M. G., Sánchez, V., Sanders, M., Stanford, J., Cook, R. S., & Arteaga, C. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65416 · Cited by 590
Wicki, A., Lehembre, F., Wick, N., Hantusch, B., Kerjaschki, D., & Christofori, G. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.010 · Cited by 579
Gulhati, P., Bowen, K. A., Liu, J., Stevens, P. D., Rychahou, P. G., Chen, M., Lee, E. Y., Weiss, H. L., O'Connor, K. L., Gao, T., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4058 · Cited by 543
Comito, G., Giannoni, E., Segura, C. P., Barcellos-de-Souza, P., Raspollini, M. R., Baroni, G., Lanciotti, M., Serni, S., & Chiarugi, P. (2014) · Oncogene · doi:10.1038/onc.2013.191 · Cited by 528
Acidic pH enhances the invasive behavior of human melanoma cells
Mart�nez-Zaguil�n, R., Seftor, E. A., Seftor, R. E. B., Chu, Y.-W., Gillies, R. J., & Hendrix, M. J. C. (1996) · Clinical & Experimental Metastasis · doi:10.1007/bf00121214 · Cited by 507
Yauch, R. L., Januario, T., Eberhard, D. A., Cavet, G., Zhu, W., Fu, L., Pham, T. Q., Soriano, R., Stinson, J., Seshagiri, S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1492 · Cited by 495
Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis
Bowman, T., Broome, M. A., Sinibaldi, D., Wharton, W., Pledger, W. J., Sedivy, J. M., Irby, R., Yeatman, T., Courtneidge, S. A., & Jove, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131568898 · Cited by 488
Mulholland, D. J., Kobayashi, N., Ruscetti, M., Zhi, A., Tran, L. M., Huang, J., Gleave, M., & Wu, H. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3132 · Cited by 478
Suppression of cancer relapse and metastasis by inhibiting cancer stemness
Li, Y., Rogoff, H. A., Keates, S., Gao, Y., Murikipudi, S., Mikule, K., Leggett, D., Li, W., Pardee, A. B., & Li, C. J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424171112 · Cited by 458
Huang, R. Y.-J., Wong, M. K., Tan, T. Z., Kuay, K. T., Ng, A. H. C., Chung, V. Y., Chu, Y.-S., Matsumura, N., Lai, H.-C., Lee, Y. F., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.442 · Cited by 427
Src signaling in cancer invasion
Guarino, M. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22011 · Cited by 426
Leight, J. L., Wozniak, M. A., Chen, S., Lynch, M. L., & Chen, C. S. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-06-0537 · Cited by 425
Bhowmick, N. A., Zent, R., Ghiassi, M., McDonnell, M., & Moses, H. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106176200 · Cited by 388
Immune-Induced Epithelial to Mesenchymal Transition In vivo Generates Breast Cancer Stem Cells
Santisteban, M., Reiman, J. M., Asiedu, M. K., Behrens, M. D., Nassar, A., Kalli, K. R., Haluska, P., Ingle, J. N., Hartmann, L. C., Manjili, M. H., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3343 · Cited by 379
Chang, L., Graham, P. H., Hao, J., Ni, J., Bucci, J., Cozzi, P. J., Kearsley, J. H., & Li, Y. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.407 · Cited by 377
Autocrine PDGFR signaling promotes mammary cancer metastasis
Jechlinger, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24652 · Cited by 371
Toh, B., Wang, X., Keeble, J., Sim, W. J., Khoo, K., Wong, W.-C., Kato, M., Prevost-Blondel, A., Thiery, J.-P., & Abastado, J.-P. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001162 · Cited by 369
Colorectal Cancer Stem Cells: From the Crypt to the Clinic
Zeuner, A., Todaro, M., Stassi, G., & De Maria, R. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.11.012 · Cited by 368
Self-citationMcConkey, D. J., Choi, W., Marquis, L., Martin, F., Williams, M. B., Shah, J., Svatek, R., Das, A., Adam, L., Kamat, A., et al. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-009-9194-7 · Cited by 368
Adipocyte-derived endotrophin promotes malignant tumor progression
Park, J., & Scherer, P. E. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63930 · Cited by 350
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells
Bartucci, M., Dattilo, R., Moriconi, C., Pagliuca, A., Mottolese, M., Federici, G., Benedetto, A. D., Todaro, M., Stassi, G., Sperati, F., et al. (2015) · Oncogene · doi:10.1038/onc.2014.5 · Cited by 350
Self-citationTargeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche
Lock, F. E., McDonald, P. C., Lou, Y., Serrano, I., Chafe, S. C., Ostlund, C., Aparicio, S., Winum, J.-Y., Supuran, C. T., & Dedhar, S. (2013) · Oncogene · doi:10.1038/onc.2012.550 · Cited by 348
Liu, J., Liao, S., Diop-Frimpong, B., Chen, W., Goel, S., Naxerova, K., Ancukiewicz, M., Boucher, Y., Jain, R. K., & Xu, L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117610109 · Cited by 330
MicroRNA-21: A novel therapeutic target in human cancer
Pan, X., Wang, Z.-X., & Wang, R. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.12.14252 · Cited by 322
Protein Kinase C α Is a Central Signaling Node and Therapeutic Target for Breast Cancer Stem Cells
Tam, W. L., Lu, H., Buikhuisen, J., Soh, B. S., Lim, E., Reinhardt, F., Wu, Z. J., Krall, J. A., Bierie, B., Guo, W., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.005 · Cited by 321
Colomiere, M., Ward, A. C., Riley, C., Trenerry, M. K., Cameron-Smith, D., Findlay, J., Ackland, L., & Ahmed, N. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604794 · Cited by 320
Xiong, H., Hong, J., Du, W., Lin, Y.-W., Ren, L.-L., Wang, Y.-C., Su, W.-Y., Wang, J.-L., Cui, Y., Wang, Z.-H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.295964 · Cited by 307
Targeting the HGF/c-MET Pathway in Hepatocellular Carcinoma
Goyal, L., Muzumdar, M. D., & Zhu, A. X. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2791 · Cited by 307
Metformin: Multi-faceted protection against cancer
Del Barco, S., Vazquez-Martin, A., Cufí, S., Oliveras-Ferraros, C., Bosch-Barrera, J., Joven, J., Martin-Castillo, B., & Menendez, J. A. (2011) · Oncotarget · doi:10.18632/oncotarget.387 · Cited by 302
Induction of Heart Valve Lesions by Small-Molecule ALK5 Inhibitors
Anderton, M. J., Mellor, H. R., Bell, A., Sadler, C., Pass, M., Powell, S., Steele, S. J., Roberts, R. R. A., & Heier, A. (2011) · Toxicologic Pathology · doi:10.1177/0192623311416259 · Cited by 284
De Milito, A., Canese, R., Marino, M. L., Borghi, M., Iero, M., Villa, A., Venturi, G., Lozupone, F., Iessi, E., Logozzi, M., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25009 · Cited by 274
Wu, Y., Ginther, C., Kim, J., Mosher, N., Chung, S., Slamon, D., & Vadgama, J. V. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0155-t · Cited by 268
Eades, G., Yao, Y., Yang, M., Zhang, Y., Chumsri, S., & Zhou, Q. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.229401 · Cited by 263
Transforming Growth Factor-β as a Therapeutic Target in Hepatocellular Carcinoma
Giannelli, G., Villa, E., & Lahn, M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0243 · Cited by 263
Fransvea, E., Angelotti, U., Antonaci, S., & Giannelli, G. (2008) · Hepatology · doi:10.1002/hep.22201 · Cited by 253
Yokobori, T., Iinuma, H., Shimamura, T., Imoto, S., Sugimachi, K., Ishii, H., Iwatsuki, M., Ota, D., Ohkuma, M., Iwaya, T., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-0326 · Cited by 249
Notch signaling: switching an oncogene to a tumor suppressor
Lobry, C., Oh, P., Mansour, M. R., Look, A. T., & Aifantis, I. (2014) · Blood · doi:10.1182/blood-2013-08-355818 · Cited by 249
Sun, L., Yao, Y., Liu, B., Lin, Z., Lin, L., Yang, M., Zhang, W., Chen, W., Pan, C., Liu, Q., et al. (2012) · Oncogene · doi:10.1038/onc.2011.263 · Cited by 249
Merlin Deficiency Predicts FAK Inhibitor Sensitivity: A Synthetic Lethal Relationship
Shapiro, I. M., Kolev, V. N., Vidal, C. M., Kadariya, Y., Ring, J. E., Wright, Q., Weaver, D. T., Menges, C., Padval, M., McClatchey, A. I., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008639 · Cited by 249
Zhang, Q., Bai, X., Chen, W., Ma, T., Hu, Q., Liang, C., Xie, S., Chen, C., Hu, L., Xu, S., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt027 · Cited by 248
Yen, W.-C., Fischer, M. M., Axelrod, F., Bond, C., Cain, J., Cancilla, B., Henner, W. R., Meisner, R., Sato, A., Shah, J., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2808 · Cited by 246
Infante, J. R., Camidge, D. R., Mileshkin, L. R., Chen, E. X., Hicks, R. J., Rischin, D., Fingert, H., Pierce, K. J., Xu, H., Roberts, W. G., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.9346 · Cited by 242
Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle
Arvizo, R. R., Saha, S., Wang, E., Robertson, J. D., Bhattacharya, R., & Mukherjee, P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214547110 · Cited by 237
Rodon, J., Carducci, M. A., Sepulveda-Sánchez, J. M., Azaro, A., Calvo, E., Seoane, J., Braña, I., Sicart, E., Gueorguieva, I., Cleverly, A. L., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1380 · Cited by 235
Li, L., Han, R., Xiao, H., Lin, C., Wang, Y., Liu, H., Li, K., Chen, H., Sun, F., Yang, Z., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2613 · Cited by 234
Immune Escape and Survival Mechanisms in Circulating Tumor Cells of Colorectal Cancer
Steinert, G., Schölch, S., Niemietz, T., Iwata, N., García, S. A., Behrens, B., Voigt, A., Kloor, M., Benner, A., Bork, U., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1885 · Cited by 233
Wong, C. C.-L., Zhang, H., Gilkes, D. M., Chen, J., Wei, H., Chaturvedi, P., Hubbi, M. E., & Semenza, G. L. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0855-y · Cited by 225
Lombardo, Y., Scopelliti, A., Cammareri, P., Todaro, M., Iovino, F., Ricci–Vitiani, L., Gulotta, G., Dieli, F., de Maria, R., & Stassi, G. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.005 · Cited by 222
Self-citationZheng, L., Yang, W., Wu, F., Wang, C., Yu, L., Tang, L., Qiu, B., Li, Y., Guo, L., Wu, M., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0203 · Cited by 221
Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy
El-Haibi, C. P., Bell, G. W., Zhang, J., Collmann, A. Y., Wood, D., Scherber, C. M., Csizmadia, E., Mariani, O., Zhu, C., Campagne, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206653109 · Cited by 218
Selective targeting of radiation-resistant tumor-initiating cells
Zhang, M., Atkinson, R. L., & Rosen, J. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910179107 · Cited by 216
Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer
Vanharanta, S., Shu, W., Brenet, F., Hakimi, A. A., Heguy, A., Viale, A., Reuter, V. E., Hsieh, J. J.-D., Scandura, J. M., & Massagué, J. (2013) · Nature Medicine · doi:10.1038/nm.3029 · Cited by 215
A systems view of epithelial–mesenchymal transition signaling states
Thomson, S., Petti, F., Sujka-Kwok, I., Mercado, P., Bean, J., Monaghan, M., Seymour, S. L., Argast, G. M., Epstein, D. M., & Haley, J. D. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-010-9367-3 · Cited by 211
Dumont, N., Wilson, M. B., Crawford, Y. G., Reynolds, P. A., Sigaroudinia, M., & Tlsty, T. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807146105 · Cited by 210
Mejlvang, J., Kriajevska, M., Vandewalle, C., Chernova, T., Sayan, A. E., Berx, G., Mellon, J. K., & Tulchinsky, E. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-05-0406 · Cited by 207
Role of Focal Adhesion Kinase in Regulating YB–1–Mediated Paclitaxel Resistance in Ovarian Cancer
Kang, Y., Hu, W., Ivan, C., Dalton, H. J., Miyake, T., Pecot, C. V., Zand, B., Liu, T., Huang, J., Jennings, N. B., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt210 · Cited by 204
Acquired Resistance to Anti-VEGF Therapy in Glioblastoma Is Associated with a Mesenchymal Transition
Piao, Y., Liang, J., Holmes, L., Henry, V., Sulman, E., & de Groot, J. F. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1557 · Cited by 200
Cieply, B., Farris, J., Denvir, J., Ford, H. L., & Frisch, S. M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4082 · Cited by 193
Thomson, S., Petti, F., Sujka-Kwok, I., Epstein, D., & Haley, J. D. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9200-4 · Cited by 190
Shi, Z., Zhang, J., Qian, X., Han, L., Zhang, K., Chen, L., Liu, J., Ren, Y., Yang, M., Zhang, A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0280 · Cited by 190
Targeting ROR1 Inhibits Epithelial–Mesenchymal Transition and Metastasis
Cui, B., Zhang, S., Chen, L., Yu, J., Widhopf, G. F., Fecteau, J.-F., Rassenti, L. Z., & Kipps, T. J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3832 · Cited by 187
Pickup, M. W., Laklai, H., Acerbi, I., Owens, P., Gorska, A. E., Chytil, A., Aakre, M., Weaver, V. M., & Moses, H. L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0012 · Cited by 187
Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapy
Zhang, S., Cui, B., Lai, H., Liu, G., Ghia, E. M., Widhopf, G. F., Zhang, Z., Wu, C. C. N., Chen, L., Wu, R., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419599111 · Cited by 186
A new tumor suppressor role for the Notch pathway in bladder cancer
Rampias, T., Vgenopoulou, P., Avgeris, M., Polyzos, A., Stravodimos, K., Valavanis, C., Scorilas, A., & Klinakis, A. (2014) · Nature Medicine · doi:10.1038/nm.3678 · Cited by 184
Screening therapeutic EMT blocking agents in a three-dimensional microenvironment
Aref, A. R., Huang, R. Y.-J., Yu, W., Chua, K.-N., Sun, W., Tu, T.-Y., Bai, J., Sim, W.-J., Zervantonakis, I. K., Thiery, J. P., et al. (2013) · Integr. Biol. · doi:10.1039/c2ib20209c · Cited by 183
Drake, J. M., Strohbehn, G., Bair, T. B., Moreland, J. G., & Henry, M. D. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-10-1076 · Cited by 177
Vultur, A., Buettner, R., Kowolik, C., Liang, W., Smith, D., Boschelli, F., & Jove, R. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0126 · Cited by 170
Gill, B. J., Gibbons, D. L., Roudsari, L. C., Saik, J. E., Rizvi, Z. H., Roybal, J. D., Kurie, J. M., & West, J. L. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0895 · Cited by 170
Chou, C.-C., Lee, K.-H., Lai, I.-L., Wang, D., Mo, X., Kulp, S. K., Shapiro, C. L., & Chen, C.-S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0135 · Cited by 170
Yuan, Y. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1275 · Cited by 166
Buonato, J. M., & Lazzara, M. J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-12-4721 · Cited by 166
Philips, G. M., Chan, I. S., Swiderska, M., Schroder, V. T., Guy, C., Karaca, G. F., Moylan, C., Venkatraman, T., Feuerlein, S., Syn, W.-K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023943 · Cited by 165
Smith, D. C., Eisenberg, P. D., Manikhas, G., Chugh, R., Gubens, M. A., Stagg, R. J., Kapoun, A. M., Xu, L., Dupont, J., & Sikic, B. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1373 · Cited by 162
CHUNG, S. S., GIEHL, N., WU, Y., & VADGAMA, J. V. (2014) · International Journal of Oncology · doi:10.3892/ijo.2013.2195 · Cited by 161
Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer
Bosurgi, L., Bernink, J. H., Cuevas, V. D., Gagliani, N., Joannas, L. D., Schmid, E. T., Booth, C. J., Ghosh, S., & Rothlin, C. V. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1302507110 · Cited by 160
Gucalp, A., Sparano, J. A., Caravelli, J., Santamauro, J., Patil, S., Abbruzzi, A., Pellegrino, C., Bromberg, J., Dang, C., Theodoulou, M., et al. (2011) · Clinical Breast Cancer · doi:10.1016/j.clbc.2011.03.021 · Cited by 159
Current status of SRC inhibitors in solid tumor malignancies
Puls, L. N., Eadens, M., & Messersmith, W. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0408 · Cited by 158
Hypoxia-induced genetic instability—a calculated mechanism underlying tumor progression
Huang, E. L., Bindra, R. S., Glazer, P. M., & Harris, A. L. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0133-6 · Cited by 158
Qu, C., Zhang, W., Zheng, G., Zhang, Z., Yin, J., & He, Z. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1845-x · Cited by 152
AXL Inhibition Sensitizes Mesenchymal Cancer Cells to Antimitotic Drugs
Wilson, C., Ye, X., Pham, T., Lin, E., Chan, S., McNamara, E., Neve, R. M., Belmont, L., Koeppen, H., Yauch, R. L., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1009 · Cited by 150
Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibition
WILSON, C. A., Nicholes, K., Bustos, D. J., Lin, E., Song, Q., Stéphan, J.-P., Kirkpatrick, D. S., & Settleman, J. (2014) · Oncotarget · doi:10.18632/oncotarget.2397 · Cited by 149
Yue, P., Zhang, X., Paladino, D., Sengupta, B., Ahmad, S., Holloway, R. W., Ingersoll, S. B., & Turkson, J. (2011) · Oncogene · doi:10.1038/onc.2011.409 · Cited by 140
Whissell, G., Montagni, E., Martinelli, P., Hernando‐Momblona, X., Sevillano, M., Jung, P., Cortina, C., Calon, A., Abulí, A., Castells, A., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb2992 · Cited by 140
Cañadas, I., Rojo, F., Taus, Á., Arpí, O., Arumí-Uría, M., Pijuán, L., Menéndez, S., Zazo, S., Dómine, M., Salido, M., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1330 · Cited by 140
Fiaschi, T., Giannoni, E., Taddei, L., Cirri, P., Marini, A., Pintus, G., Nativi, C., Richichi, B., Scozzafava, A., Carta, F., et al. (2013) · Cell Cycle · doi:10.4161/cc.24902 · Cited by 139
Chen, E. Y., DeRan, M., Ignatius, M. S., Grandinetti, K. B., Clagg, R., McCarthy, K. M., Lobbardi, R., Brockmann, J., Keller, C., Wu, X., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317731111 · Cited by 139
Große-Steffen, T., Giese, T., Giese, N. A., Longerich, T., Schirmacher, P., Hänsch, G. M., & Gaida, M. M. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/720768 · Cited by 138
Zhang, Z., Dong, Z., Lauxen, I. S., Filho, M. S., & Nor, J. E. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2032 · Cited by 132
Fang, H., Wu, Y., Huang, X., Wang, W., Ang, B., Cao, X., & Wan, T. Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.266528 · Cited by 131
PI3K/mTOR Dual Inhibitor VS-5584 Preferentially Targets Cancer Stem Cells
Kolev, V. N., Wright, Q. G., Vidal, C. M., Ring, J. E., Shapiro, I. M., Ricono, J. M., Weaver, D. T., Padval, M. V., Pachter, J. A., & Xu, Q. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1223 · Cited by 127
Zhong, Z., Carroll, K. D., Policarpio, D., Osborn, C., Gregory, M., Bassi, R., Jimenez, X., Prewett, M., Liebisch, G., Persaud, K., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1634 · Cited by 123
Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients’ bed
Ferrari, S., Perut, F., Fagioli, F., del Prever, A. B., Meazza, C., Parafioriti, A., Picci, P., Gambarotti, M., Avnet, S., Baldini, N., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-268 · Cited by 123
miR-200b Inhibits Prostate Cancer EMT, Growth and Metastasis
Williams, L. V., Veliceasa, D., Vinokour, E. I., & Volpert, O. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083991 · Cited by 121
Leconet, W., Larbouret, C., Chardès, T., Thomas, G., Neiveyans, M., Busson, M., Jarlier, M., Radosevic‐Robin, N., Pugnière, M., Bernex, F., et al. (2013) · Oncogene · doi:10.1038/onc.2013.487 · Cited by 116
Jeong, H., Ryu, Y.-J., An, J., Lee, Y., & Kim, A. (2012) · Histopathology · doi:10.1111/j.1365-2559.2012.04195.x · Cited by 116
Hypoxia-Inducible Factor 1α Mediates Anoikis Resistance via Suppression of α5 Integrin
Rohwer, N., Welzel, M., Daskalow, K., Pfander, D., Wiedenmann, B., Detjen, K. M., & Cramer, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1839 · Cited by 114
Sun, S., Liu, S., Duan, S. Z., Zhang, L., Zhou, H., Hu, Y., Zhou, X., Shi, C., Zhou, R., & Zhang, Z. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0826 · Cited by 111
Coppola, V., Musumeci, M., Patrizii, M., Cannistraci, A., Addario, A., Maugeri‐Saccà, M., Biffoni, M., Francescangeli, F., Cordenonsi, M., Piccolo, S., et al. (2012) · Oncogene · doi:10.1038/onc.2012.194 · Cited by 110
Kumar, M., Allison, D. F., Baranova, N. N., Wamsley, J. J., Katz, A. J., Bekiranov, S., Jones, D. R., & Mayo, M. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068597 · Cited by 107
Histone Deacetylase Inhibitors Induce Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells
Kong, D., Ahmad, A., Bao, B., Li, Y., Banerjee, S., & Sarkar, F. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045045 · Cited by 107
First Axl inhibitor enters clinical trials
Sheridan, C. (2013) · Nature Biotechnology · doi:10.1038/nbt0913-775a · Cited by 105
To “Grow” or “Go”: TMEM16A Expression as a Switch between Tumor Growth and Metastasis in SCCHN
Shiwarski, D. J., Shao, C., Bill, A., Kim, J., Xiao, D., Bertrand, C. A., Seethala, R. S., Sano, D., Myers, J. N., Ha, P. K., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0363 · Cited by 105
Sunaga, N., Imai, H., Shimizu, K., Shames, D. S., Kakegawa, S., Girard, L., Sato, M., Kaira, K., Ishizuka, T., Gazdar, A. F., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26164 · Cited by 103
Parvani, J. G., Galliher-Beckley, A. J., Schiemann, B. J., & Schiemann, W. P. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-10-0776 · Cited by 102
Bailey, K. M., & Liu, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709329200 · Cited by 101
Rudin, C. M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0568 · Cited by 101
Devarajan, E., Song, Y., Krishnappa, S., & Alt, E. (2011) · International Journal of Cancer · doi:10.1002/ijc.26493 · Cited by 100
Jiang, G., Wang, H., Zhang, F., Zhang, K.-S., Liu, Z., Fang, R., Wang, H., Cai, S., & Du, J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.12.002 · Cited by 100
Pantuck, A. J., An, J., Liu, H., & Rettig, M. B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2211 · Cited by 100
Taylor, M. A., Amin, J., Kirschmann, D. A., & Schiemann, W. P. (2011) · Neoplasia · doi:10.1593/neo.101086 · Cited by 96
PRRX1 promotes epithelial–mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer
Guo, J., Fu, Z., Wei, J., Lü, W., Feng, J., & Zhang, S. (2014) · Medical Oncology · doi:10.1007/s12032-014-0393-x · Cited by 95
Gjorevski, N., Boghaert, E., & Nelson, C. M. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0076-5 · Cited by 94
Cheng, Z., Sun, B., Wang, S., Gao, Y., Zhang, Y., Zhou, H., Jia, G., Wang, Y., Kong, R., Pan, S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023752 · Cited by 91
Role of β5-integrin in epithelial-mesenchymal transition in response to TGF-β
Bianchi, A., Gervasi, M. E., & Bakin, A. V. (2010) · Cell Cycle · doi:10.4161/cc.9.8.11517 · Cited by 88
Shah, P., Gau, Y., & Sabnis, G. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2784-7 · Cited by 86
Chua, K. N., Sim, W.-J., Racine, V., Lee, S.-Y., Goh, B. C., & Thiery, J. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033183 · Cited by 85
Fan, H., Zhao, X., Sun, S., Luo, M., & Guan, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.420497 · Cited by 85
Grygielewicz, P., Dymek, B., Bujak, A., Gunerka, P., Stanczak, A. M., Lamparska‐Przybysz, M., Wieczorek, M., Dzwonek, K., & Zdżalik-Bielecka, D. (2014) · Gastric Cancer · doi:10.1007/s10120-014-0444-1 · Cited by 74
Shimojo, Y., Akimoto, M., Hisanaga, T., Tanaka, T., Tajima, Y., Honma, Y., & Takenaga, K. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9519-8 · Cited by 73
Yamashina, T., Baghdadi, M., Yoneda, A., Kinoshita, I., Suzu, S., Dosaka‐Akita, H., & Jinushi, M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2169 · Cited by 72
Chen, J., Chen, G., Yan, Z., Guo, Y., Yu, M., Feng, L., Jiang, Z., Guo, W., & Tian, W. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24610 · Cited by 68
Veiseh, M., Kwon, D. H.-M., Borowsky, A. D., Tölg, C., Leong, H. S., Lewis, J. D., Turley, E. A., & Bissell, M. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402383111 · Cited by 68
A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells
Tate, C. M., D, R. P. M., Ricci‐Vitiani, L., Dowless, M. S., Shiyanova, T. L., D’Alessandris, Q. G., Morgante, L., Giannetti, S., Larocca, L. M., Martino, S. D., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.44 · Cited by 67
Zhang, Y., Zhang, W., & Qin, L. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201309885 · Cited by 67
Salgia, R., Patel, P. H., Bothos, J. G., Yu, W., Eppler, S., Hegde, P. S., Bai, S., Kaur, S., Nijem, I., Catenacci, D. V. T., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2070 · Cited by 66
Marcucci, F., Bellone, M., Caserta, C. A., & Corti, A. (2013) · International Journal of Cancer · doi:10.1002/ijc.28572 · Cited by 64
Self-citationLu, H., Wang, L., Gao, W. X., Meng, J., Dai, B., Wu, S., Minna, J. D., Roth, J. A., Hofstetter, W. L., Swisher, S. G., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0233 · Cited by 64
Shin, S. R., Sánchez-Velar, N., Sherr, D. H., & Sonenshein, G. E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3056 · Cited by 60
Somlo, G., Atzori, F., Strauss, L. C., Geese, W. J., Specht, J. M., Gradishar, W. J., Rybicki, A., Sy, O., Vahdat, L. T., & Cortés, J. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0652 · Cited by 55
Yang, X., Li, S., Li, W., Chen, J., Xiao, X., Wang, Y., Yan, G., & Chen, L. (2012) · Oncology Reports · doi:10.3892/or.2012.2146 · Cited by 54
Wallin, J. J., Guan, J., Edgar, K. A., Zhou, W., Francis, R., Torres, A. C., Haverty, P. M., Eastham‐Anderson, J., Arena, S., Bardelli, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036402 · Cited by 50
Lin, G., Gai, R., Chen, Z., Wang, Y., Liao, S., Dong, R., Zhu, H., Gu, Y., He, Q., & Yang, B. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.02.011 · Cited by 48
Fleuren, E. D. G., Hillebrandt-Roeffen, M. H. S., Flucke, U. E., Loo, D. M. W. M. T., Boerman, O. C., van der Graaf, W. T. A., & Versleijen‐Jonkers, Y. M. H. (2014) · Oncotarget · doi:10.18632/oncotarget.2648 · Cited by 47
Activation of NADPH oxidase subunit NCF4 induces ROS-mediated EMT signaling in HeLa cells
Kim, Y., & Cho, M. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2013.12.005 · Cited by 44
Palagani, V., Khatib, M. E., Kossatz-Boehlert, U., Bozko, P. M., Müller, M., Manns, M. P., Krech, T., Malek, N. P., & Plentz, R. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046514 · Cited by 42
Ashizawa, T., Akiyama, Y., Miyata, H., Iizuka, A., Komiyama, M., Kume, A., Omiya, M., Sugino, T., Asai, A., Hayashi, N., et al. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2439 · Cited by 38
Gallardo‐Pérez, J. C., Rivero-Segura, N. A., Marín‐Hernández, Á., Moreno‐Sánchez, R., & Rodríguez‐Enríquez, S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.01.013 · Cited by 30
Chen, W., Wu, S.-P., Zhang, G., Wang, W., & SHI, Y. (2013) · Oncology Letters · doi:10.3892/ol.2013.1552 · Cited by 26
Zhong, L., Fu, X., Zou, C., Yang, L., Zhou, S. W., Yang, J., Tang, Y., Cheng, C., Li, L., Xiang, R., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28944 · Cited by 22
Azmi, A. S., Bollig-Fischer, A. B., Bao, B., Park, B.-J., Lee, S., Yong-Song, G., Dyson, G. E., Reddy, C. K. A., Sarkar, F. H., & Mohammad, R. M. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-85 · Cited by 21
Cited by
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Shibue, T., & Weinberg, R. A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.44 · Cited by 2,539
Epithelial Mesenchymal Transition in Tumor Metastasis
Mittal, V. (2018) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043854 · Cited by 1,528
Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing
Kim, C., Gao, R., Sei, E., Brandt, R., Hartman, J., Hatschek, T., Crosetto, N., Foukakis, T., & Navin, N. E. (2018) · Cell · doi:10.1016/j.cell.2018.03.041 · Cited by 1,104
Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies
Zhou, Q., Meng, Y., Li, D., Yao, L., Le, J., Liu, Y., Sun, Y., Zeng, F., Chen, X., & Deng, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01769-5 · Cited by 890
Epithelial–mesenchymal transition in tumor metastasis
Yeung, K. T., & Yang, J. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12017 · Cited by 723
Metadata
- Authors
- Marcucci, F., Stassi, G., & De Maria, R.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2016-01-29
- Volume
- 15
- Issue
- 5
- Pages
- 311-325
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2264801869
- Cited by
- 342
- References
- 200
- FWCI
- 5.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.